Sysmex Corporation (SSMXY) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Instruments & Supplies secteur d'activité. Le siège social de l'entreprise est situé à Kobe, Japan. Le PDG actuel est Hisashi Ietsugu.
SSMXY a date d'introduction en bourse 2011-10-17, 10,042 employés à temps plein, cotée sur le Other OTC, une capitalisation boursière de $5.5B.
Sysmex Corporation is a Japanese diagnostic instrument manufacturer headquartered in Kobe that develops, manufactures, and sells hematology analyzers, immunochemistry systems, flow cytometers, and related reagents and software globally. The company's product portfolio includes white blood cell differentiation instruments, urine analysis systems, infectious disease and tumor marker assays, cancer diagnostic systems, and digital medicine platforms, serving hospitals, research institutions, and medical centers across approximately 190 countries. Beyond diagnostic instruments, Sysmex provides laboratory information system software, facility management services, nucleic acid analogs, IT solutions, and medical robotics, with a strategic alliance with QIAGEN for cancer companion diagnostics development. Founded in 1968, the company has established itself as a comprehensive in vitro diagnostics provider serving both public and private healthcare institutions worldwide.
